BridgeBio Oncology Therapeutics, Inc. (BBOT)

CIK 1869105 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for BridgeBio Oncology Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 2026EFFECT9999999995-26-002939
Sep 8, 20268-K0001193125-26-385225
Sep 8, 2026EFFECT9999999995-26-002909
Sep 1, 2026POS AM0001193125-26-378366
Sep 1, 2026S-30001193125-26-378637
Aug 12, 2026424B30001193125-26-345123
Aug 11, 20268-K0001193125-26-344608
Aug 11, 202610-Q0001193125-26-344661
Jul 6, 202640001193125-26-296503
Jul 6, 202640001213900-26-075538
Jul 6, 2026SCHEDULE 13D/A0001213900-26-075546
Jul 6, 202640001193125-26-296504
Jul 6, 202640001193125-26-296501
Jul 6, 202640001193125-26-296502
Jun 22, 20268-K0001193125-26-277513
Jun 22, 2026424B30001193125-26-277572
Jun 18, 202640001193125-26-276043
Jun 18, 202640001193125-26-276048
Jun 18, 202640001193125-26-276035
Jun 18, 202640001193125-26-276050
Jun 18, 202640001193125-26-276046
Jun 18, 202640001193125-26-276033
Jun 18, 202640001193125-26-276041
May 13, 2026424B30001193125-26-221560
May 12, 202610-Q0001193125-26-219829